GNLX
GENELUX Corp
Company overview
- Market capitalization
- $111.76M
- Employees
- 25
- Latest publication
- 2026-09-29
About GENELUX Corp
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 8,000USD | 0USD | 0USD | 452,000USD | 896,000USD | 0USD | 0USD |
| Cost Of Revenue | 1,000USD | 148,000USD | — | 143,000USD | 139,000USD | 452,000USD | 224,000USD | 204,000USD |
| Gross Profit | -1,000USD | -140,000USD | — | -143,000USD | -139,000USD | -227,000USD | -224,000USD | -204,000USD |
| Research Development | 5,244,000USD | 5,654,000USD | 4,741,000USD | 4,758,000USD | 4,698,000USD | 6,520,000USD | 4,051,000USD | 4,417,000USD |
| Selling General Administrative | 3,120,000USD | 3,766,000USD | 3,453,000USD | 3,034,000USD | 3,118,000USD | 3,228,000USD | 2,890,000USD | 2,475,000USD |
| Total Operating Expenses | 8,364,000USD | 9,272,000USD | 8,194,000USD | 7,649,000USD | 7,816,000USD | 9,748,000USD | 6,941,000USD | 6,688,000USD |
| Operating Income | -8,365,000USD | -9,412,000USD | -8,194,000USD | -7,792,000USD | -7,816,000USD | -9,748,000USD | -6,941,000USD | -6,892,000USD |
| Interest Income | 243,000USD | 165,000USD | 244,000USD | 336,000USD | 324,000USD | 402,000USD | 474,000USD | 316,000USD |
| Net Interest Income | 243,000USD | 165,000USD | 244,000USD | 336,000USD | 324,000USD | 402,000USD | 474,000USD | 316,000USD |
| Income Before Tax | -7,125,000USD | -9,247,000USD | -7,950,000USD | -7,456,000USD | -7,492,000USD | -8,976,000USD | -6,467,000USD | -6,576,000USD |
| Net Income | -7,125,000USD | -9,247,000USD | -7,950,000USD | -7,456,000USD | -7,492,000USD | -8,976,000USD | -6,467,000USD | -6,576,000USD |
| Net Income From Continuing Ops | -8,928,000USD | -9,247,000USD | -7,950,000USD | -7,456,000USD | -7,492,000USD | -8,976,000USD | -6,467,000USD | -6,576,000USD |
| Ebit | -7,125,000USD | -9,992,000USD | -7,950,000USD | -7,456,000USD | -7,492,000USD | -8,976,000USD | -6,467,000USD | -6,576,000USD |
| Ebitda | -7,080,000USD | -9,844,000USD | -7,806,000USD | -7,313,000USD | -7,353,000USD | -8,749,000USD | -6,243,000USD | -6,372,000USD |
| Depreciation And Amortization | 45,000USD | 148,000USD | 144,000USD | 143,000USD | 139,000USD | 227,000USD | 224,000USD | 204,000USD |
| Reconciled Depreciation | 98,000USD | 148,000USD | 144,000USD | 143,000USD | 139,000USD | 227,000USD | 224,000USD | 204,000USD |
| Total Other Income Expense Net | 1,240,000USD | 165,000USD | 244,000USD | 336,000USD | 324,000USD | 772,000USD | 474,000USD | 316,000USD |
| Interest Expense | — | — | — | — | — | 0USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 204,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 8,000USD | 8,000USD | 11,068,000USD | 0USD | 0USD | — |
| Cost Of Revenue | 574,000USD | 903,000USD | 968,000USD | 895,000USD | 658,000USD | 477,000USD |
| Gross Profit | -566,000USD | -895,000USD | 10,100,000USD | -895,000USD | -658,000USD | -477,000USD |
| Research Development | 19,851,000USD | 18,998,000USD | 9,078,000USD | 6,319,000USD | 6,227,000USD | 7,532,000USD |
| Selling General Administrative | 13,371,000USD | 12,706,000USD | 5,003,000USD | 8,294,000USD | 6,195,000USD | 3,129,000USD |
| Total Operating Expenses | 32,648,000USD | 30,801,000USD | 13,113,000USD | 13,718,000USD | 11,764,000USD | 10,870,000USD |
| Operating Income | -33,214,000USD | -31,696,000USD | -3,013,000USD | -14,613,000USD | -12,422,000USD | -10,870,000USD |
| Interest Income | 1,069,000USD | 1,457,000USD | 0USD | — | — | — |
| Net Interest Income | 1,069,000USD | 1,457,000USD | -1,408,000USD | -1,815,000USD | -1,221,000USD | — |
| Income Before Tax | -32,145,000USD | -29,869,000USD | -4,107,000USD | -16,378,000USD | -13,643,000USD | -11,631,000USD |
| Net Income | -32,145,000USD | -29,869,000USD | -5,207,000USD | -17,795,000USD | -14,864,000USD | -11,631,000USD |
| Net Income From Continuing Ops | -32,145,000USD | -29,869,000USD | -5,207,000USD | -16,378,000USD | -13,643,000USD | — |
| Ebit | -32,145,000USD | -29,869,000USD | -2,699,000USD | -14,563,000USD | -12,422,000USD | -10,870,000USD |
| Ebitda | -31,571,000USD | -28,966,000USD | -1,731,000USD | -13,668,000USD | -11,764,000USD | -10,494,000USD |
| Depreciation And Amortization | 574,000USD | 903,000USD | 968,000USD | 895,000USD | 658,000USD | 376,000USD |
| Reconciled Depreciation | 574,000USD | 903,000USD | 968,000USD | 895,000USD | 658,000USD | — |
| Total Other Income Expense Net | 1,069,000USD | 1,827,000USD | -1,094,000USD | -1,765,000USD | -1,221,000USD | -761,000USD |
| Interest Expense | — | 0USD | 1,408,000USD | 1,815,000USD | 1,221,000USD | 761,000USD |
| Income Tax Expense | — | — | 1,100,000USD | 1,417,000USD | 1,221,000USD | — |
| Tax Provision | — | — | 1,100,000USD | 0USD | — | — |
| Net Income Applicable To Common Shares | — | — | -5,207,000USD | -16,378,000USD | -13,643,000USD | -11,631,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 209,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 26,205,000USD | 32,372,000USD | 19,027,000USD | 24,987,000USD | 32,247,000USD | 38,985,000USD | 34,716,000USD | 40,270,000USD |
| Cash And Equivalents | 9,184,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 18,684,000USD | 26,209,000USD | 14,595,000USD | 19,915,000USD | 27,972,000USD | 35,102,000USD | 30,895,000USD | 34,057,000USD |
| Short Term Investments | 9,500,000USD | 16,936,000USD | 9,262,000USD | 16,223,000USD | 21,426,000USD | 18,896,000USD | 22,330,000USD | 27,955,000USD |
| Total Current Assets | 19,144,000USD | 26,754,000USD | 15,130,000USD | 21,552,000USD | 29,235,000USD | 35,945,000USD | 31,548,000USD | 35,967,000USD |
| Other Current Assets | 474,000USD | 545,000USD | 535,000USD | 1,637,000USD | 1,263,000USD | 843,000USD | 653,000USD | 1,910,000USD |
| Other Non Current Assets | 146,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,092,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 7,998,000USD | 7,272,000USD | 6,225,000USD | 5,126,000USD | 6,988,000USD | 7,689,000USD | 6,903,000USD | 5,555,000USD |
| Total Stockholder Equity | 16,113,000USD | 22,921,000USD | 11,544,000USD | 18,591,000USD | 23,898,000USD | 29,846,000USD | 26,274,000USD | 33,091,000USD |
| Total Equity Including Noncontrolling Interest | 16,113,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 6,915,000USD | 5,474,000USD | 3,753,000USD | 3,312,000USD | 2,939,000USD | 2,967,000USD | 3,076,000USD | 3,208,000USD |
| Accounts Payable | 6,918,000USD | 6,095,000USD | 4,358,000USD | 3,987,000USD | 6,033,000USD | 6,688,000USD | 5,570,000USD | 4,454,000USD |
| Short Term Debt | 326,000USD | 316,000USD | 427,000USD | 354,000USD | 345,000USD | 337,000USD | 329,000USD | 830,000USD |
| Common Stock | 45,000USD | 45,000USD | 38,000USD | 38,000USD | 38,000USD | 38,000USD | 35,000USD | 35,000USD |
| Retained Earnings | -301,937,000USD | -292,466,000USD | -283,538,000USD | -274,291,000USD | -266,341,000USD | -258,885,000USD | -251,393,000USD | -242,417,000USD |
| Accumulated Other Comprehensive Income | -2,000USD | -5,000USD | 9,000USD | 8,000USD | 3,000USD | 29,000USD | 64,000USD | 124,000USD |
| Total Liab | — | 9,451,000USD | 7,483,000USD | 6,396,000USD | 8,349,000USD | 9,139,000USD | 8,442,000USD | 7,179,000USD |
| Other Current Liab | — | 861,000USD | 1,440,000USD | 785,000USD | 610,000USD | 664,000USD | 1,004,000USD | 686,000USD |
| Capital Stock | — | 45,000USD | 38,000USD | 38,000USD | 38,000USD | 38,000USD | 35,000USD | 35,000USD |
| Cash | — | 9,273,000USD | 5,333,000USD | 3,692,000USD | 6,546,000USD | 16,206,000USD | 8,565,000USD | 6,102,000USD |
| Net Debt | — | -6,778,000USD | -3,648,000USD | -2,068,000USD | -4,840,000USD | -14,419,000USD | -6,697,000USD | -4,063,000USD |
| Short Long Term Debt Total | — | 2,495,000USD | 1,685,000USD | 1,624,000USD | 1,706,000USD | 1,787,000USD | 1,868,000USD | 2,039,000USD |
| Property Plant Equipment Gross | — | 9,411,000USD | 7,680,000USD | 7,180,000USD | 6,745,000USD | 6,710,000USD | 6,760,000USD | 6,835,000USD |
| Common Stock Shares Outstanding | — | 32,500,000shares | 37,176,527shares | 37,893,314shares | 37,946,330shares | 34,926,075shares | 31,450,727shares | 34,532,355shares |
| Non Current Assets Total | — | 5,618,000USD | 3,897,000USD | 3,435,000USD | 3,012,000USD | 3,040,000USD | 3,168,000USD | 4,303,000USD |
| Non Current Liabilities Total | — | 2,179,000USD | 1,258,000USD | 1,270,000USD | 1,361,000USD | 1,450,000USD | 1,539,000USD | 1,624,000USD |
| Non Currrent Assets Other | — | 144,000USD | 144,000USD | 123,000USD | 73,000USD | 73,000USD | 92,000USD | 92,000USD |
| Net Working Capital | — | 19,482,000USD | 8,905,000USD | 16,426,000USD | 22,247,000USD | 28,256,000USD | 24,645,000USD | 30,412,000USD |
| Unclassified Non Current Liabilities | — | 2,179,000USD | 1,258,000USD | 1,270,000USD | 1,361,000USD | 1,450,000USD | 1,539,000USD | 1,624,000USD |
| Unclassified Equity | — | 315,302,000USD | 294,997,000USD | 292,798,000USD | 290,160,000USD | 288,626,000USD | 277,533,000USD | 275,314,000USD |
| Long Term Investments | — | — | — | — | — | — | — | 1,003,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 19,027,000USD | 34,716,000USD | 27,893,000USD | 5,531,000USD | 8,126,000USD | 14,008,000USD | 3,281,000USD |
| Other Current Assets | 535,000USD | 653,000USD | 1,012,000USD | 1,495,000USD | 2,654,000USD | 127,000USD | 126,000USD |
| Total Liab | 7,483,000USD | 8,442,000USD | 8,420,000USD | 41,314,000USD | 41,237,000USD | 36,663,000USD | 28,092,000USD |
| Total Stockholder Equity | 11,544,000USD | 26,274,000USD | 19,473,000USD | -35,783,000USD | -33,111,000USD | -22,655,000USD | -24,811,000USD |
| Other Current Liab | 1,440,000USD | 1,004,000USD | 2,117,000USD | 8,016,000USD | 6,964,000USD | 9,676,000USD | 10,118,000USD |
| Common Stock | 38,000USD | 35,000USD | 27,000USD | 9,000USD | 9,000USD | 27,000USD | 24,000USD |
| Capital Stock | 38,000USD | 35,000USD | 27,000USD | 31,000USD | 31,000USD | 31,000USD | — |
| Retained Earnings | -283,538,000USD | -251,393,000USD | -221,524,000USD | -189,784,000USD | -184,577,000USD | -168,228,000USD | -154,585,000USD |
| Cash | 5,333,000USD | 8,565,000USD | 9,418,000USD | 397,000USD | 4,495,000USD | 11,350,000USD | 425,000USD |
| Cash And Short Term Investments | 14,595,000USD | 30,895,000USD | 23,191,000USD | 397,000USD | 4,495,000USD | 11,350,000USD | 425,000USD |
| Total Current Assets | 15,130,000USD | 31,548,000USD | 24,203,000USD | 1,892,000USD | 5,822,000USD | 11,477,000USD | 551,000USD |
| Total Current Liabilities | 6,225,000USD | 6,903,000USD | 6,554,000USD | 31,626,000USD | 22,483,000USD | 14,493,000USD | 14,726,000USD |
| Net Debt | -3,648,000USD | -6,697,000USD | -6,899,000USD | 25,956,000USD | 20,816,000USD | 14,710,000USD | 17,549,000USD |
| Short Term Debt | 427,000USD | 329,000USD | 1,306,000USD | 16,665,000USD | 6,557,000USD | 3,890,000USD | 4,608,000USD |
| Short Long Term Debt Total | 1,685,000USD | 1,868,000USD | 2,519,000USD | 26,353,000USD | 25,311,000USD | 26,060,000USD | 17,974,000USD |
| Short Term Investments | 9,262,000USD | 22,330,000USD | 13,773,000USD | 0USD | — | — | — |
| Accounts Payable | 4,358,000USD | 5,570,000USD | 3,784,000USD | 6,775,000USD | 4,462,000USD | 927,000USD | 3,634,000USD |
| Property Plant Equipment Net | 3,753,000USD | 3,076,000USD | 3,598,000USD | 1,979,000USD | 2,212,000USD | 2,451,000USD | 2,650,000USD |
| Property Plant Equipment Gross | 7,680,000USD | 6,760,000USD | 7,047,000USD | 4,929,000USD | 4,609,000USD | 4,295,000USD | — |
| Accumulated Other Comprehensive Income | 9,000USD | 64,000USD | 14,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Common Stock Shares Outstanding | 37,176,527shares | 31,450,727shares | 24,429,278shares | 24,553,470shares | 23,615,424shares | 23,615,424shares | 23,615,424shares |
| Non Current Assets Total | 3,897,000USD | 3,168,000USD | 3,690,000USD | 3,639,000USD | 2,304,000USD | 2,531,000USD | 2,730,000USD |
| Non Current Liabilities Total | 1,258,000USD | 1,539,000USD | 1,866,000USD | 9,688,000USD | 18,754,000USD | 22,170,000USD | 13,366,000USD |
| Non Currrent Assets Other | 144,000USD | 92,000USD | 92,000USD | 1,660,000USD | 92,000USD | 80,000USD | 80,000USD |
| Net Working Capital | 8,905,000USD | 24,645,000USD | 17,649,000USD | -29,734,000USD | -16,661,000USD | -3,016,000USD | — |
| Unclassified Non Current Liabilities | 1,258,000USD | 1,539,000USD | 1,866,000USD | — | — | — | 13,366,000USD |
| Unclassified Equity | 294,997,000USD | 277,533,000USD | 240,929,000USD | 153,959,000USD | 151,424,000USD | 145,513,000USD | 129,748,000USD |
| Deferred Long Term Liab | — | — | — | 1,568,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | 170,000USD | 4,500,000USD | — | — |
| Short Long Term Debt | — | — | — | 16,399,000USD | 6,155,000USD | 3,605,000USD | — |
| Long Term Debt | — | — | — | 8,524,000USD | 18,023,000USD | 21,694,000USD | — |
| Unclassified Current Liabilities | — | — | — | -16,399,000USD | -6,155,000USD | -3,605,000USD | -3,634,000USD |
| Other Assets | — | — | — | — | 92,000USD | 80,000USD | 80,000USD |
| Net Tangible Assets | — | — | — | — | -33,133,000USD | -22,677,000USD | -24,833,000USD |
| Unclassified Current Assets | — | — | — | — | -1,327,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 20,000USD |
| Change To Liabilities | 2,562,000USD |
| Change In Working Capital | 2,619,000USD |
| Operating Cash Flow | -12,503,000USD |
| Capital Expenditures | -2,453,000USD |
| Net Investments | -14,398,000USD |
| Unclassified Investing Cash Flow | 14,280,000USD |
| Investing Cash Flow | -2,571,000USD |
| Financing Cash Flow | 18,925,000USD |
| Change In Cash | 3,851,000USD |
| End Cash Flow | 9,184,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -9,247,000USD | -7,950,000USD | -7,456,000USD | -7,492,000USD | -8,976,000USD | -6,467,000USD | -6,576,000USD | -7,850,000USD |
| Depreciation | 135,000USD | 144,000USD | -174,000USD | 139,000USD | 227,000USD | -830,000USD | 204,000USD | 248,000USD |
| Stock Based Compensation | 810,000USD | 2,348,000USD | 1,284,000USD | 1,429,000USD | 1,430,000USD | 1,201,000USD | 1,304,000USD | 1,803,000USD |
| Other Non Cash Items | 1,088,000USD | 259,000USD | 498,000USD | -37,000USD | 127,000USD | -784,000USD | -17,000USD | 838,000USD |
| Change In Working Capital | 1,014,999USD | -1,376,000USD | -1,211,000USD | 526,000USD | 2,890,000USD | 1,132,000USD | -1,739,000USD | 607,000USD |
| Total Cash From Operating Activities | -6,199,000USD | -6,575,000USD | -7,059,000USD | -5,435,000USD | -4,302,000USD | -5,748,000USD | -6,824,000USD | -4,354,000USD |
| Capital Expenditures | -436,000USD | -517,000USD | -115,000USD | -30,000USD | -96,000USD | -27,000USD | -228,000USD | -30,000USD |
| Free Cash Flow | -6,635,000USD | -7,092,000USD | -7,174,000USD | -5,465,000USD | -4,398,000USD | -5,775,000USD | -7,052,000USD | -4,384,000USD |
| Investments | 7,000,000USD | 4,721,000USD | -2,653,000USD | 3,509,000USD | 6,674,000USD | 3,992,000USD | -17,106,000USD | -1,691,000USD |
| Total Cashflows From Investing Activities | 6,564,000USD | 4,721,000USD | -2,653,000USD | 3,509,000USD | 6,674,000USD | 3,992,000USD | -17,106,000USD | -1,691,000USD |
| Total Cash From Financing Activities | 276,000USD | 0USD | 52,000USD | 9,567,000USD | 91,000USD | 0USD | 27,727,000USD | 688,000USD |
| Issuance Of Capital Stock | 52,000USD | 0USD | 52,000USD | 9,553,000USD | 91,000USD | 49,000USD | 27,678,000USD | 0USD |
| Change In Cash | 641,000USD | -1,854,000USD | -9,660,000USD | 7,641,000USD | 2,463,000USD | -1,756,000USD | 3,797,000USD | -5,357,000USD |
| Begin Period Cash Flow | 4,692,000USD | 6,546,000USD | 16,206,000USD | 8,565,000USD | 6,102,000USD | 7,858,000USD | 4,061,000USD | 9,418,000USD |
| End Period Cash Flow | 5,333,000USD | 4,692,000USD | 6,546,000USD | 16,206,000USD | 8,565,000USD | 6,102,000USD | 7,858,000USD | 4,061,000USD |
| Other Cashflows From Financing Activities | 9,881,000USD | — | — | 14,000USD | — | -49,000USD | 49,000USD | 688,000USD |
| Unclassified Financing Cash Flow | -9,657,000USD | — | — | — | — | — | — | — |
| Net Borrowings | — | — | — | — | 0USD | 0USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -32,145,000USD | -29,869,000USD | -28,297,000USD | -5,207,000USD | -11,631,000USD |
| Depreciation | 244,000USD | 903,000USD | 1,018,000USD | 968,000USD | 477,000USD |
| Stock Based Compensation | 5,871,000USD | 6,070,000USD | 5,204,000USD | 2,415,000USD | — |
| Other Non Cash Items | 1,808,000USD | 917,000USD | 5,081,000USD | -56,000USD | 3,847,000USD |
| Change In Working Capital | -1,046,000USD | 751,000USD | -3,281,000USD | -1,691,000USD | 84,000USD |
| Total Cash From Operating Activities | -25,268,000USD | -21,228,000USD | -20,275,000USD | -3,571,000USD | -7,223,000USD |
| Capital Expenditures | -1,098,000USD | -381,000USD | -1,025,000USD | -49,000USD | -1,771,000USD |
| Free Cash Flow | -26,366,000USD | -21,609,000USD | -21,300,000USD | -3,620,000USD | -8,994,000USD |
| Investments | 13,239,000USD | -8,131,000USD | -782,000USD | -49,000USD | — |
| Total Cashflows From Investing Activities | 12,141,000USD | -8,131,000USD | -14,724,000USD | -49,000USD | -1,771,000USD |
| Total Cash From Financing Activities | 9,895,000USD | 28,506,000USD | 44,020,000USD | -478,000USD | 7,888,000USD |
| Issuance Of Capital Stock | 9,657,000USD | 27,818,000USD | 39,645,000USD | 14,503,000USD | — |
| Change In Cash | -3,232,000USD | -853,000USD | 9,021,000USD | -4,098,000USD | -1,106,000USD |
| Begin Period Cash Flow | 8,565,000USD | 9,418,000USD | 397,000USD | 4,495,000USD | 1,531,000USD |
| End Period Cash Flow | 5,333,000USD | 8,565,000USD | 9,418,000USD | 397,000USD | 425,000USD |
| Other Cashflows From Financing Activities | 9,895,000USD | 688,000USD | 4,160,000USD | -1,448,000USD | -1,771,000USD |
| Unclassified Financing Cash Flow | -9,657,000USD | — | — | -14,503,000USD | 8,154,000USD |
| Net Borrowings | — | 0USD | 215,000USD | 970,000USD | 1,505,000USD |
| Unclassified Investing Cash Flow | — | — | -12,917,000USD | — | — |
| Change To Liabilities | — | — | — | -4,330,000USD | -406,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.